Epizódjegyzetek
Episode 158 — 03 November 2026
Examining how ESG metrics reshape drug pricing, RWE's expanding role in HTA, and the impact of AI on evidence generation.
Hosted by Marcus and Sara.
Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.
Full transcript and sources at outcomes-analytica.no/podcast

